Cargando…
Identifying metabolic features of colorectal cancer liability using Mendelian randomization
BACKGROUND: Recognizing the early signs of cancer risk is vital for informing prevention, early detection, and survival. METHODS: To investigate whether changes in circulating metabolites characterise the early stages of colorectal cancer (CRC) development, we examined associations between a genetic...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029059/ https://www.ncbi.nlm.nih.gov/pubmed/36945480 http://dx.doi.org/10.1101/2023.03.10.23287084 |
_version_ | 1785145836683919360 |
---|---|
author | Bull, Caroline J. Hazelwood, Emma Bell, Joshua A. Tan, Vanessa Y. Constantinescu, Andrei-Emil Borges, Maria Carolina Legge, Danny N. Burrows, Kimberly Huyghe, Jeroen R. Brenner, Hermann Castellví-Bel, Sergi Chan, Andrew T Kweon, Sun-Seog Marchand, Loic Le Li, Li Cheng, Iona Pai, Rish K. Figueiredo, Jane C. Murphy, Neil Gunter, Marc J. Timpson, Nicholas J. Vincent, Emma E. |
author_facet | Bull, Caroline J. Hazelwood, Emma Bell, Joshua A. Tan, Vanessa Y. Constantinescu, Andrei-Emil Borges, Maria Carolina Legge, Danny N. Burrows, Kimberly Huyghe, Jeroen R. Brenner, Hermann Castellví-Bel, Sergi Chan, Andrew T Kweon, Sun-Seog Marchand, Loic Le Li, Li Cheng, Iona Pai, Rish K. Figueiredo, Jane C. Murphy, Neil Gunter, Marc J. Timpson, Nicholas J. Vincent, Emma E. |
author_sort | Bull, Caroline J. |
collection | PubMed |
description | BACKGROUND: Recognizing the early signs of cancer risk is vital for informing prevention, early detection, and survival. METHODS: To investigate whether changes in circulating metabolites characterise the early stages of colorectal cancer (CRC) development, we examined associations between a genetic risk score (GRS) associated with CRC liability (72 single nucleotide polymorphisms) and 231 circulating metabolites measured by nuclear magnetic resonance spectroscopy in the Avon Longitudinal Study of Parents and Children (N=6,221). Linear regression models were applied to examine associations between genetic liability to colorectal cancer and circulating metabolites measured in the same individuals at age 8, 16, 18 and 25 years. RESULTS: The GRS for CRC was associated with up to 28% of the circulating metabolites at FDR-P<0.05 across all time points, particularly with higher fatty acids and very-low- and low-density lipoprotein subclass lipids. Two-sample reverse Mendelian randomization (MR) analyses investigating CRC liability (52,775 cases, 45,940 controls) and metabolites measured in a random subset of UK Biobank participants (N=118,466, median age 58y) revealed broadly consistent effect estimates with the GRS analysis. In conventional (forward) MR analyses, genetically predicted polyunsaturated fatty acid concentrations were most strongly associated with higher CRC risk. CONCLUSIONS: These analyses suggest that higher genetic liability to CRC can cause early alterations in systemic metabolism, and suggest that fatty acids may play an important role in CRC development. FUNDING: This work was supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol, the Wellcome Trust, the Medical Research Council, Diabetes UK, the University of Bristol NIHR Biomedical Research Centre, and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work used the computational facilities of the Advanced Computing Research Centre, University of Bristol - http://www.bristol.ac.uk/acrc/. |
format | Online Article Text |
id | pubmed-10029059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-100290592023-11-14 Identifying metabolic features of colorectal cancer liability using Mendelian randomization Bull, Caroline J. Hazelwood, Emma Bell, Joshua A. Tan, Vanessa Y. Constantinescu, Andrei-Emil Borges, Maria Carolina Legge, Danny N. Burrows, Kimberly Huyghe, Jeroen R. Brenner, Hermann Castellví-Bel, Sergi Chan, Andrew T Kweon, Sun-Seog Marchand, Loic Le Li, Li Cheng, Iona Pai, Rish K. Figueiredo, Jane C. Murphy, Neil Gunter, Marc J. Timpson, Nicholas J. Vincent, Emma E. medRxiv Article BACKGROUND: Recognizing the early signs of cancer risk is vital for informing prevention, early detection, and survival. METHODS: To investigate whether changes in circulating metabolites characterise the early stages of colorectal cancer (CRC) development, we examined associations between a genetic risk score (GRS) associated with CRC liability (72 single nucleotide polymorphisms) and 231 circulating metabolites measured by nuclear magnetic resonance spectroscopy in the Avon Longitudinal Study of Parents and Children (N=6,221). Linear regression models were applied to examine associations between genetic liability to colorectal cancer and circulating metabolites measured in the same individuals at age 8, 16, 18 and 25 years. RESULTS: The GRS for CRC was associated with up to 28% of the circulating metabolites at FDR-P<0.05 across all time points, particularly with higher fatty acids and very-low- and low-density lipoprotein subclass lipids. Two-sample reverse Mendelian randomization (MR) analyses investigating CRC liability (52,775 cases, 45,940 controls) and metabolites measured in a random subset of UK Biobank participants (N=118,466, median age 58y) revealed broadly consistent effect estimates with the GRS analysis. In conventional (forward) MR analyses, genetically predicted polyunsaturated fatty acid concentrations were most strongly associated with higher CRC risk. CONCLUSIONS: These analyses suggest that higher genetic liability to CRC can cause early alterations in systemic metabolism, and suggest that fatty acids may play an important role in CRC development. FUNDING: This work was supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol, the Wellcome Trust, the Medical Research Council, Diabetes UK, the University of Bristol NIHR Biomedical Research Centre, and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work used the computational facilities of the Advanced Computing Research Centre, University of Bristol - http://www.bristol.ac.uk/acrc/. Cold Spring Harbor Laboratory 2023-11-09 /pmc/articles/PMC10029059/ /pubmed/36945480 http://dx.doi.org/10.1101/2023.03.10.23287084 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Bull, Caroline J. Hazelwood, Emma Bell, Joshua A. Tan, Vanessa Y. Constantinescu, Andrei-Emil Borges, Maria Carolina Legge, Danny N. Burrows, Kimberly Huyghe, Jeroen R. Brenner, Hermann Castellví-Bel, Sergi Chan, Andrew T Kweon, Sun-Seog Marchand, Loic Le Li, Li Cheng, Iona Pai, Rish K. Figueiredo, Jane C. Murphy, Neil Gunter, Marc J. Timpson, Nicholas J. Vincent, Emma E. Identifying metabolic features of colorectal cancer liability using Mendelian randomization |
title | Identifying metabolic features of colorectal cancer liability using Mendelian randomization |
title_full | Identifying metabolic features of colorectal cancer liability using Mendelian randomization |
title_fullStr | Identifying metabolic features of colorectal cancer liability using Mendelian randomization |
title_full_unstemmed | Identifying metabolic features of colorectal cancer liability using Mendelian randomization |
title_short | Identifying metabolic features of colorectal cancer liability using Mendelian randomization |
title_sort | identifying metabolic features of colorectal cancer liability using mendelian randomization |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029059/ https://www.ncbi.nlm.nih.gov/pubmed/36945480 http://dx.doi.org/10.1101/2023.03.10.23287084 |
work_keys_str_mv | AT bullcarolinej identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT hazelwoodemma identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT belljoshuaa identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT tanvanessay identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT constantinescuandreiemil identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT borgesmariacarolina identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT leggedannyn identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT burrowskimberly identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT huyghejeroenr identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT brennerhermann identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT castellvibelsergi identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT chanandrewt identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT kweonsunseog identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT marchandloicle identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT lili identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT chengiona identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT pairishk identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT figueiredojanec identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT murphyneil identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT guntermarcj identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT timpsonnicholasj identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization AT vincentemmae identifyingmetabolicfeaturesofcolorectalcancerliabilityusingmendelianrandomization |